Biofrontera AG (GB:0DOL)
LSE:0DOL
Holding GB:0DOL?
Track your performance easily

Biofrontera (0DOL) Financial Statements

0 Followers

Biofrontera Financial Overview

Biofrontera's market cap is currently ―. The company's EPS TTM is €-0.42; its P/E ratio is -33.97; Biofrontera is scheduled to report earnings on April 24, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Mar 23
Income Statement-
Total Revenue€ 7.84M€ 7.91M€ 10.59M€ 8.90M€ 8.73M
Gross Profit€ 7.84M€ 7.91M€ 5.20M€ 4.31M€ 8.73M
EBIT€ 359.00K€ -3.54M-€ -6.19M€ -2.15M
EBITDA€ 659.00K€ -3.25M-€ -5.93M€ -1.89M
Net Income Common Stockholders€ -257.00K€ -10.44M€ 3.53M€ -6.34M€ -7.48M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments€ 4.38M€ 3.82M€ 1.34M€ 3.42M€ 21.10M
Total Assets€ 21.57M€ 24.57M€ 27.93M€ 34.10M€ 41.97M
Total Debt€ 1.44M€ 3.67M€ 5.40M€ 2.81M€ 1.21M
Net Debt€ -2.94M€ -151.00K€ 4.06M€ -608.00K€ -19.89M
Total Liabilities€ 10.66M€ 26.42M€ 23.14M€ 33.07M€ 25.21M
Stockholders Equity€ 10.91M€ -5.42M€ 4.79M€ 1.04M€ 16.75M
Cash Flow-
Free Cash Flow€ -4.63M€ -3.38M--€ -3.70M
Operating Cash Flow€ -4.67M€ -3.33M€ -8.87M€ -2.00M€ -3.69M
Investing Cash Flow€ -45.00K€ 43.00K€ 73.00K€ 382.00K€ -14.00K
Financing Cash Flow€ 5.28M€ 5.80M€ 6.71M€ 591.00K-
Currency in EUR

Biofrontera Earnings and Revenue History

Biofrontera Debt to Assets

Biofrontera Cash Flow

Biofrontera Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis